摘要:We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML).
关键词:Chronic myeloid leukemia ; Line of therapy ; Tyrosine Kinase inhibitors